Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
79,376,583
-
Total 13F shares
-
56,372,656
-
Share change
-
+8,330,972
-
Total reported value
-
$2,631,606,875
-
Put/Call ratio
-
117%
-
Price per share
-
$46.69
-
Number of holders
-
156
-
Value change
-
+$394,199,729
-
Number of buys
-
96
-
Number of sells
-
64
Institutional Holders of Akero Therapeutics, Inc. - COMMON STOCK (AKRO) as of Q2 2023
As of 30 Jun 2023,
Akero Therapeutics, Inc. - COMMON STOCK (AKRO) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,372,656 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, ALKEON CAPITAL MANAGEMENT LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, FMR LLC, BAKER BROS. ADVISORS LP, STATE STREET CORP, and PERCEPTIVE ADVISORS LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.